Front. Mol. Biosci. Frontiers in Molecular Biosciences Front. Mol. Biosci. 2296-889X Frontiers Media S.A. 887178 10.3389/fmolb.2022.887178 Molecular Biosciences Correction Corrigendum: Immune Response in Myocardial Injury: In Situ Hybridization and Immunohistochemistry Techniques for SARS-CoV-2 Detection in COVID-19 Autopsies Chong et al. Corrigendum: Myocardial Injury in COVID-19 Infection Chong Pek Yoon 1 Iqbal Jabed 2 * Yeong Joe 3 Aw Tar Choon 1 Chan Kian Sing 4 Chui Paul 5 1 Department of Pathology, Sengkang General Hospital, Singapore, Singapore 2 Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore 3 Institute of Molecular and Cell Biology, A-STAR, Singapore, Singapore 4 Department of Molecular Pathology, Singapore General Hospital, Singapore, Singapore 5 Health Science Authority, Singapore, Singapore

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

 *Correspondence: Jabed Iqbal, jabed.iqbal@singhealth.com.sg

This article was submitted to Molecular Diagnostics and Therapeutics, a section of the journal Frontiers in Molecular Biosciences

 31 03 2022 2022 9 887178 01 03 2022 02 03 2022 Copyright © 2022 Chong, Iqbal, Yeong, Aw, Chan and Chui. 2022 Chong, Iqbal, Yeong, Aw, Chan and Chui

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Immune Response in Myocardial Injury: In Situ Hybridization and Immunohistochemistry Techniques for SARS-CoV-2 Detection in COVID-19 Autopsies by Chong, P. Y., Iqbal, J., Yeong, J., Aw, T. C., Chan, K. S., and Chui, P. (2021). Front. Mol. Biosci. 8:658932. doi: 10.3389/fmolb.2021.658932 PCR autopsy multiplex serology COVID-19

In the original article, we neglected to include the Funder “SingHealth Duke-NUS Pathology Academic Clinical Program (ACP).”

The corrected Funding statement appears below:

“This publication was funded by SingHealth Duke-NUS Pathology Academic Clinical Program (ACP).”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.